Skip to main content




Agenda

DAY 1

Monday, September 24

Opening Lectures
Alice Campbell Alumni Center, 601 S. Lincoln Avenue, Urbana

7:00pm

Maryn McKenna
Journalist; Senior Fellow, Schuster Institute for Investigative Journalism, Brandeis University
"The History and Future of Antibiotic Resistance Policy”

Ramanan Laxminarayan
Center for Disease Dynamics, Economics and Policy
"The State of the World’s Antibiotics in 2018"

 


 

DAY 2

Tuesday, September 25

Session Speakers
612 Carl R. Woese Institute for Genomic Biology, 1206 W. Gregory Drive, Urbana

7:30am

Breakfast


8:30-8:45am

Opening Remarks

Wilfred van der Donk
Richard E. Heckert Endowed Chair in Chemistry
University of Illinois at Urbana-Champaign

Session 1
Antimicrobial Resistance: Policy and Research

Chair: Brenda Wilson

8:45-9:15am

Jean Patel
Centers for Disease Control and Prevention
"The Biggest Antibiotic Resistant Threats"


9:15-9:45am

Brad Spellberg
University of Southern California
“The Future of Antibiotics and Resistance”


9:45-10:15am

Lynn Silver
LL Silver Consulting, LLC
"Target Choice and its Relation to Rapid Mutational Resistance"


10:15-10:45am

Break


10:45-11:15am

Gerard Wright
McMaster University
"Looking in New Places: Using Genomic Natural History to Find Antibiotics"


11:15-12:00pm

Roundtable Discussion


12:00-1:00pm

Lunch

Session 2
Antimicrobial Resistance: New Initiatives + Approaches

Chair: Paul Hergenrother

1:00-1:30pm

Douglas Mitchell
University of Illinois at Urbana-Champaign
"The Outpace Antibiotic Resistance Initiative at Illinois: Cracking the 15 versus 2 Problem"


1:30-2:00pm

Vincent Fischetti
The Rockefeller University
“Exploiting Phage Evolution for the Development of Novel Therapeutics”


2:00-2:30pm

Deborah Hung
Harvard Medical School/Broad Institute, MIT
"A Systems Chemical Biological Approach to Antibiotic Discovery"


2:30-3:00pm

Break


3:00-3:30pm

Clifton Barry III
National Institute of Allergy and Infectious Diseases
“The Future of Oxazolidinones in the Treatment of Drug-Resistant Tuberculosis”


3:30-4:00pm

Peter Smith
Genentech
"Optimization of the Arylomycins into a New Class of Gram-Negative Antibiotics"


4:00-4:45pm

Roundtable Discussion